Dagnon Terry
SEC CIK 1760510 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| OTLK | Outlook Therapeutics, Inc. | Chief Ops Off | 653.1K | $59.5K | $592.8K | 4 | 2021-12-03 | 2023-04-20 |
Most active insiders at OTLK, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Sukhtian Ghiath M. | Dir, 10% | $7.50M | — |
| 2 | HILZINGER KURT J | Dir | $176.5K | — |
| 3 | Sukhtian Faisal Ghiath | Dir | $150.0K | — |
| 4 | Haddadin Yezan Munther | Dir | $39.1K | — |
| 5 | THURMAN RANDY H | Dir | $2,145 | — |
| 6 | Jahr Robert Charles | CEO, Dir | — | — |
| 7 | KENYON LAWRENCE A | CFO, Dir | — | — |
Dagnon Terry made no open-market trades at OTLK in the last 12 months.
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-04-21 | 2023-04-20 | OTLK | Outlook Therapeutics, Inc. | Dagnon Terry | Chief Ops Off | S - Sale | $1.14 | -520.0K | 653.1K | -44% | -$592.8K | |
| 2022-06-23 | 2022-06-21 | OTLK | Outlook Therapeutics, Inc. | Dagnon Terry | COO | P - Purchase | $1.05 | +10.0K | 1.17M | +0.9% | +$10.5K | |
| 2021-12-06 | 2021-12-06 | OTLK | Outlook Therapeutics, Inc. | Dagnon Terry | COO | P - Purchase | $1.38 | +25.2K | 1.16M | +2% | +$34.8K | |
| 2021-12-03 | 2021-12-03 | OTLK | Outlook Therapeutics, Inc. | Dagnon Terry | COO | P - Purchase | $1.42 | +10.0K | 1.14M | +0.9% | +$14.2K |
Purchase Sale Sale after option exercise All abbreviations